Literature DB >> 7294008

Chronic progressive renal failure. Rate of progression monitored by change of serum creatinine concentration.

E W Reimold.   

Abstract

The rise of serum creatinine levels during were renal failure progressing to end-stage renal disease was studied in 30 children. In 20 patients the rise was a steady one and followed a mathematical model, best expressed by the regression line calculated from reciprocal values. Ten patients had widely fluctuating values that did not fit any of the available mathematical models; however, in three patients, the curve had two slopes. The initially slow rate of progression changed to a more rapid, steady rise when a creatinine level of 2 to 3 mg/dL was reached. Therefore, in 23 of 30 patients, the time at which a serum creatinine values of 10 mg/dL would be reached could be predicted with acceptable accuracy based on this calculation or using a graphic plot. In the terminal phase of renal failure, the serum creatinine value progressed from 7 to 10 mg/dL in less than four months in 80% of the cases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7294008     DOI: 10.1001/archpedi.1981.02130350039013

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  3 in total

1.  Rate of deterioration of renal function in juvenile nephronophthisis.

Authors:  N Gretz; K Schärer; R Waldherr; M Strauch
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

2.  Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine.

Authors:  W A Gahl; J A Schneider; J D Schulman; J G Thoene; G F Reed
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

Review 3.  Chronic kidney disease prediction is an inexact science: The concept of "progressors" and "nonprogressors".

Authors:  Macaulay Amechi Chukwukadibia Onuigbo; Nneoma Agbasi
Journal:  World J Nephrol       Date:  2014-08-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.